AdvaMedDx hosted an all-member educational session on the diagnostics regulatory reform bill, The VALID Act of 2021.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
Read the full text of the VALID Act of 2021 as submitted to the 117th Congress.
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
AdvaMedDx wrote to affirm our commitment to make modernization of the regulatory framework for IVCTs a reality.
Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.
AdvaMedDx has prepared a high-level FAQ document that addresses key questions you may receive about the bill.
AdvaMed: VALID Act an “Important Step Toward the Long-Overdue Modernization” of Law Governing Diagnostic Tests
AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon re-introduction today in the House and Senate of the Verifying Accurate, Leading-edge…
Advancing Diagnostics Together: In-Person & Virtual offerings with complete coverage of the most timely and important issues for the diagnostics industry.
The VALID Act marks a milestone in AdvaMedDx efforts to secure a diagnostic-specific, risk-based and modernized for innovation, regulation of all diagnostic tests – LDTs and IVDs.